Incorporating initial treatments improves performance of a mortality prediction model for patients with sepsis

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL.2, 2012, Pages 44-52

  Lagu, Tara ^a,b   Rothberg, Michael B ^a,b   Nathanson, Brian H ^c   Steingrub, Jay S ^a,b   Lindenauer, Peter K ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OptiStatim LLC   (United States)

Author keywords

Mortality prediction; Sepsis; Severity of illness; Severity score

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL ABUSE; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLLAGEN DISEASE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTENSIVE CARE; KIDNEY FAILURE; LIVER DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MORTALITY; NEUROLOGIC DISEASE; OBESITY; PARALYSIS; PATIENT INFORMATION; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEPSIS; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84860555270     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3229     Document Type: Article

References (36)

1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383.
2. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity Measures for Use with Administrative Data. Med Care 1998; 36(1): 8-27.
3. Krumholz HM, Lin Z, Drye EE, et al. An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2011; 4(2): 243-252.
4. Krumholz HM, Wang Y, Mattera JA, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 2006; 113(13): 1693-1701.
5. Tabak YP, Johannes RS, Silber JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care 2007; 45(8): 789-805.
6. Pine M, Jordan HS, Elixhauser A, et al. Enhancement of claims data to improve risk adjustment of hospital mortality. JAMA 2007; 297(1): 71-76.
7. Pine M, Jordan HS, Elixhauser A, et al. Modifying ICD-9-CM coding of secondary diagnoses to improve risk-adjustment of inpatient mortality rates. Med Decis Making 2009; 29(1): 69-81.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13(10): 818-829.
9. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270(24): 2957-2963.
10. Higgins TL, Teres D, Copes WS, et al. Assessing contemporary intensive care unit outcome: An updated Mortality Probability Admission Model (MPM0-III)*. Crit Care Med 2007; 35(3): 827-835.
11. Keegan MT, Gajic O, Afessa B. Severity of illness scoring systems in the intensive care unit. Crit Care Med 2011; 39(1): 163-169.
12. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006; 34(5): 1297-1310.
13. Lindenauer PK, Pekow PS, Lahti MC, et al. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010; 303(23): 2359-2367.
14. Rothberg MB, Pekow PS, Lahti M, et al. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). J Hosp Med 2010; 5(5): 261-267.
15. Lagu T, Lindenauer PK, Rothberg MB, et al. Development and validation of a model that uses enhanced administrative data to predict mortality in patients with sepsis. Crit Care Med 2011; 39(11): 2425-2430.
16. Hosmer DW, Lemeshow S. Applied logistic regression. John Wiley and Sons: New York, NY, 2000.
17. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348(16): 1546-1554.
18. Lagu T, Rothberg MB, Nathanson BH, et al. The relationship between hospital spending and mortality in patients with sepsis. Arch Intern Med 2011; 171(4): 292-299.
19. Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007; 35(10): 2408.
20. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29(7): 1303-1310.
21. Lagu T, Rothberg MB, Shieh M-S, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012; 40: 754-761. Available at: Accessed October 28, 2011.
22. Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge, MA: MIT Press, 2002.
23. Rogers Regression standard errors in clustered samples. Stata Technical Bulletin 1993; 13(13): 19-23.
24. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56(2): 645-646.
25. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using stata. Stata Press: College Station, TX, 2008.
26. Neuhaus JM, Kalbfleisch JD. Between- and within-cluster covariate effects in the analysis of clustered data. Biometrics 1998; 54(2): 638-645.
27. Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 2011; 6(4): 202-209.
28. Long JS. Regression models for categorical and limited dependent variables. SAGE: Thousand Oaks, CA, 1997.
29. A Raftery Bayesian Model Selection in Social Research. Sociol Methodol 1995; 25: 111-163.
30. Heise DR. Employing Nominal Variables, Induced Variables, and Block Variables in Path Analyses. Sociol Methods Res 1972; 1(2): 147-173.
31. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154(9): 854-864.
32. Higgins TL, Kramer AA, Nathanson BH, et al. Prospective validation of the intensive care unit admission Mortality Probability Model (MPM0-III)*. Crit Care Med 2009; 37(5): 1619-1623.
33. Siontis GCM, Tzoulaki I, Ioannidis JPA. Predicting death: an empirical evaluation of predictive tools for mortality. Arch Intern Med 2011; 171(19): 1721-1726.
34. Nathanson BH, Higgins TL, Kramer AA, et al. Subgroup mortality probability models: are they necessary for specialized intensive care units? Crit Care Med 2009; 37(8): 2375-2386.
35. Murphy-Filkins R, Teres D, Lemeshow S, Hosmer DW. Effect of changing patient mix on the performance of an intensive care unit severity-of-illness model: how to distinguish a general from a specialty intensive care unit. Crit Care Med 1996; 24(12): 1968-1973.
36. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998; 97(18): 1837-1847.